Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats.
Harvey
Brandon K
BK
Neural Protection and Regeneration Section, Molecular Neuropsychiatry Branch, National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21124, USA.
Shen
Hui
H
Chen
Guann-Juh
GJ
Yoshida
Yoshihiro
Y
Wang
Yun
Y
D000077556:Alitretinoin; D000704:Analysis of Variance; D000818:Animals; D001784:Blood Gas Analysis / Q000379:methods; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002544:Cerebral Infarction / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D016207:Cytokines / Q000235:genetics / Q000627:therapeutic use*; D004622:Embryo, Mammalian; D020244:Infarction, Middle Cerebral Artery / Q000150:complications* / Q000473:pathology; D008297:Male; D000078792:Midkine; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D013778:Tetrazolium Salts; D014212:Tretinoin / Q000494:pharmacology / Q000627:therapeutic use*
D016207:Cytokines; D012333:RNA, Messenger; D013778:Tetrazolium Salts; D000078792:Midkine; D000077556:Alitretinoin; D014212:Tretinoin; C009591:triphenyltetrazolium